730 filings
10-Q
2024 Q1
ARMP
Armata Pharmaceuticals Inc
Quarterly report
7 May 24
4:25pm
8-K
ARMP
Armata Pharmaceuticals Inc
7 May 24
Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update
4:15pm
ARS
2023 FY
ARMP
Armata Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
5:03pm
DEF 14A
ARMP
Armata Pharmaceuticals Inc
Definitive proxy
29 Apr 24
5:02pm
8-K
ARMP
Armata Pharmaceuticals Inc
22 Mar 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
8:00am
8-K
pqrj4u07ygpoe
21 Mar 24
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
4:15pm
8-K
ixx6a3m5se5y vpf
4 Mar 24
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
4:03pm
S-8
ehc 0xki2x7e3a15e6
23 Jan 24
Registration of securities for employees
4:17pm
S-8
yg19718twj5tzf78
15 Nov 23
Registration of securities for employees
5:24pm
8-K
de0htdqmwghrgej
14 Nov 23
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
12:00am
UPLOAD
ny0kh4 o6nm
13 Nov 23
Letter from SEC
12:00am
CORRESP
hchhk4m0xn 774n
7 Nov 23
Correspondence with SEC
12:00am
UPLOAD
a7j35 7rn834qo
26 Oct 23
Letter from SEC
12:00am
8-K
1hnfh qo1vh
20 Sep 23
Departure of Directors or Certain Officers
8:00am
8-K
61a0z xahd8ypi
14 Aug 23
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
7:15am
ARS
byk dhue3klc64t
3 Aug 23
Annual report to shareholders
4:37pm
DEFA14A
m5o 2cmfgpw80dj8orc
3 Aug 23
Additional proxy soliciting materials
4:35pm